申请人:Eli Lilly and Company
公开号:US06107346A1
公开(公告)日:2000-08-22
The present application relates to a series of compounds, and pharmaceutical formulations thereof, of the formula ##STR1## which provide a method of inhibiting hyperlipidemia, especially hypercholesterolemia, and the pathological sequelae thereof, in mammals, including humans.
本申请涉及一系列化合物及其药物制剂,其化学式为##STR1##,可提供一种方法来抑制哺乳动物,包括人类中的高脂血症,特别是高胆固醇血症及其病理后果。